SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-036152
Filing Date
2016-08-02
Accepted
2016-08-02 08:49:15
Documents
5
Period of Report
2016-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tech20160801_8k.htm 8-K 45501
2 EXHIBIT 3.2 ex3-2.htm EX-3.2 69060
3 EXHIBIT 10.1 ex10-1.htm EX-10.1 913523
4 EXHIBIT 99.1 ex99-1.htm EX-99.1 7552
5 ex10-1img001.gif GRAPHIC 3502
  Complete submission text file 0001437749-16-036152.txt   1042074
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 161799072
SIC: 2836 Biological Products, (No Diagnostic Substances)